{"id":2059,"date":"2021-04-07T20:43:43","date_gmt":"2021-04-07T20:43:43","guid":{"rendered":"https:\/\/www.merck.ca\/en\/?page_id=2059"},"modified":"2026-08-13T11:39:05","modified_gmt":"2026-08-13T11:39:05","slug":"newsroom","status":"publish","type":"page","link":"https:\/\/www.merck.ca\/en\/newsroom\/","title":{"rendered":"News Releases"},"content":{"rendered":"\n
\n
\n
\n
\n \n\t\n\n\n\n\t\"Online\n<\/picture> <\/div>\n
\n <\/div>\n <\/div>\n\n
\n \n

News Releases<\/h1>\n \n

Our Latest News and Announcements<\/p>\n<\/div>\n \n <\/div>\n <\/div>\n\n \n<\/div>\n\n\n\n

Latest News<\/strong><\/strong><\/h2>\n\n\n\n
\n
\n

 August 13, 2026<\/p>\n<\/div>\n\n\n\n

\n

Helping Protect Others Matters to Canadians, but Vaccine Uptake Gaps Remain Ahead of the Respiratory Illness Season<\/a><\/strong><\/strong><\/strong><\/strong><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 August 3, 2026<\/p>\n<\/div>\n\n\n\n

\n

Health Canada Approves KEYTRUDA\u00ae<\/sup> for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after radical cystectomy as adjuvant treatment<\/strong><\/strong><\/a><\/strong><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 May 28, 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Congratulates Ontario Government on Expanding Pharmacy Scope to Help Improve Access to Care<\/strong><\/a><\/strong><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 May 13, 2026<\/p>\n<\/div>\n\n\n\n

\n

Health Canada approves KEYTRUDA\u00ae<\/sup> for the treatment of adult patients, in combination with paclitaxel, with or without bevacizumab, with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumours express PD-L1 (CPS \u22651) as determined by a validated test, and who have received one or two prior systemic treatment regimens<\/a><\/strong><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 April 15, 2026<\/p>\n<\/div>\n\n\n\n

\n

New Survey Shows HPV Awareness Isn\u2019t Keeping Pace with Certain HPV-Related Cancer Trends in Can<\/strong><\/a>ada<\/a><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 March 24, 2026<\/p>\n<\/div>\n\n\n\n

\n

New Public Listings for Canadians Living with Pulmonary Arterial Hypertension<\/a><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 March 18, 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada Obtains Gold Level Parity Certification from Women in Governance<\/strong><\/a><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 March 13, 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Digital Sciences Studio Expands with Second Innovation Cohort to Advance Biopharma and Digital Health Progress in North America<\/a><\/strong><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 February 17, 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Health Canada Approves KEYTRUDA SC\u2122, a subcutaneous formulation of pembrolizumab across multiple cancer indications<\/strong><\/a><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 February 5, 2026<\/p>\n<\/div>\n\n\n\n

\n

Merck Announces Health Canada Approval of ENFLONSIA\u00ae for the prevention of RSV in newborns and infants<\/a><\/strong>
<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 December 8, 2025<\/p>\n<\/div>\n\n\n\n

\n

Saskatchewan Adds CAPVAXIVE\u00ae<\/sup> to Publicly Funded Adult Immunization Program<\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 November 20, 2025<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for WINREVAIR\u00ae <\/sup>(sotatercept)<\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

 November 5, 2025<\/p>\n<\/div>\n\n\n\n

\n

Quebec Expands Public Funding for CAPVAXIVE\u00ae<\/sup><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

July 11, 2025<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada Statement on Dosing Recommendations for GARDASIL\u00ae<\/sup>9<\/strong><\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

June 20, 2025<\/p>\n<\/div>\n\n\n\n

\n

Merck Digital Sciences Studio Opens in Canada to Accelerate Biopharmaceutical Innovation<\/strong><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

March 05, 2024<\/p>\n<\/div>\n\n\n\n

\n

Merck Canada Launches Indigenous Student Scholarship<\/a><\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

\n\n\n\n

Contact Our Media Team<\/strong><\/strong><\/strong><\/h2>\n\n\n\n
This information is intended for media professionals only.<\/h5>\n\n\n\n
To ensure that customers, investors, and others receive the appropriate attention, Merck Canada media contacts may ONLY respond to calls and emails from professional journalists.<\/h5>\n\n\n\n
If you are a member of the media and would like to contact our media relations staff about Merck Canada, please use the email address below. General Media information: mediacanada@merck.com<\/a><\/h5>\n\n\n\n

This webpage is designed to provide members of the media with quick and easy access to recent information about Merck Canada. For more information about Merck Canada, please visit the Our Company<\/a> page.<\/p>\n","protected":false},"excerpt":{"rendered":"

Latest News  August 13, 2026 Helping Protect Others Matters to Canadians, but Vaccine Uptake Gaps Remain Ahead of the Respiratory Illness Season  August 3, 2026 Health Canada Approves KEYTRUDA\u00ae for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and […]<\/p>\n","protected":false},"author":207,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"editor_notices":[],"footnotes":""},"class_list":["post-2059","page","type-page","status-publish","hentry"],"yoast_head":"\nNewsroom | Merck Canada<\/title>\n<meta name=\"description\" content=\"Merck Canada in the news. Take a look at press releases and receive information about Merck Canada\u2019s products and company statements.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.merck.ca\/en\/newsroom\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Newsroom | Merck Canada\" \/>\n<meta property=\"og:description\" content=\"Merck Canada in the news. Take a look at press releases and receive information about Merck Canada\u2019s products and company statements.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.merck.ca\/en\/newsroom\/\" \/>\n<meta property=\"og:site_name\" content=\"Merck Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T11:39:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.merck.ca\\\/en\\\/newsroom\\\/\",\"url\":\"https:\\\/\\\/www.merck.ca\\\/en\\\/newsroom\\\/\",\"name\":\"Newsroom | Merck Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.merck.ca\\\/en\\\/#website\"},\"datePublished\":\"2021-04-07T20:43:43+00:00\",\"dateModified\":\"2026-08-13T11:39:05+00:00\",\"description\":\"Merck Canada in the news. Take a look at press releases and receive information about Merck Canada\u2019s products and company statements.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.merck.ca\\\/en\\\/newsroom\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.merck.ca\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.merck.ca\\\/en\\\/\",\"name\":\"Merck Canada\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.merck.ca\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Newsroom | Merck Canada","description":"Merck Canada in the news. Take a look at press releases and receive information about Merck Canada\u2019s products and company statements.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.merck.ca\/en\/newsroom\/","og_locale":"en_US","og_type":"article","og_title":"Newsroom | Merck Canada","og_description":"Merck Canada in the news. Take a look at press releases and receive information about Merck Canada\u2019s products and company statements.","og_url":"https:\/\/www.merck.ca\/en\/newsroom\/","og_site_name":"Merck Canada","article_modified_time":"2026-08-13T11:39:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.merck.ca\/en\/newsroom\/","url":"https:\/\/www.merck.ca\/en\/newsroom\/","name":"Newsroom | Merck Canada","isPartOf":{"@id":"https:\/\/www.merck.ca\/en\/#website"},"datePublished":"2021-04-07T20:43:43+00:00","dateModified":"2026-08-13T11:39:05+00:00","description":"Merck Canada in the news. Take a look at press releases and receive information about Merck Canada\u2019s products and company statements.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.merck.ca\/en\/newsroom\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.merck.ca\/en\/#website","url":"https:\/\/www.merck.ca\/en\/","name":"Merck Canada","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.merck.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/pages\/2059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/users\/207"}],"replies":[{"embeddable":true,"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/comments?post=2059"}],"version-history":[{"count":252,"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/pages\/2059\/revisions"}],"predecessor-version":[{"id":12576,"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/pages\/2059\/revisions\/12576"}],"wp:attachment":[{"href":"https:\/\/www.merck.ca\/en\/wp-json\/wp\/v2\/media?parent=2059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}